Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on July 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

EMOLLIENT LOTION

Closed
SPE2DP-26-T-4182Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract is for the procurement of 250 bottles of emollient lotion, each containing 240 ml (8 fl oz), formulated as a homogeneous, non-sterile oil-in-water or water-in-oil emulsion with a pH range of 5.0 to 8.1. The product must contain minimum quantities of water, a suitable oil, an emulsifier, and a preservative, with additional ingredients such as emulsion stabilizers, thickening agents, emollients, surfactants, humectants, coloring agents, and fragrances permitted as needed. The lotion must have a viscosity between 10,000 and 20,000 CPS at 25°C, measured using a Brookfield viscometer Model LVT with spindle no. 13 at 6 RPM, and must be stored at controlled room temperature. The unit of issue is a bottle (BT), and the product is regulated by the FDA, requiring pre-award referral for confirmation. The item is identified by NSN 6508-01-019-7181 and manufacturer part number NDC00096-0722-08 from AmerisourceBergen Drug Corp. All packaging and labeling must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-129, including barcoding and data matrix requirements. Hazardous material packaging must meet TQ requirement IP025 and FED-STD-313; non-hazardous shipments must adhere to ASTM D3951 unless superseded by the DLA Master List of Technical and Quality Requirements. Palletization must follow RP001 guidelines, and traceable freight shipping is mandatory—parcel post is prohibited. Delivery is FOB destination to the USNS MERCY at FPO AP 96672-4090, with a strict 20-day delivery window from order placement, targeting July 20, 2026. The contract requires full compliance with FAR and DFARS clauses covering small business representation, employment eligibility, trafficking in persons, sustainable products, cybersecurity safeguards, hazardous material handling, export controls, and whistleblower rights. Invoicing must be submitted through WAWF, and payment compliance is tied to DoDAAC routing. All offers must be submitted electronically via DIBBS by July 22, 202

General Info

240 mL emollient lotion, pH 5.0–8.1, viscosity 10K–20K CPS, 250 bottles, delivered by July 20, 2026, to FPO AP 96672-4090.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

USNS MERCY T AH 19, FPO, AP, 96672-4090, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4182 Medical Supply Chain Pharma

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA

Full Description

Show more
EMOLLIENT LOTION
EMOLLIENT LOTION
.
HOMOGENEOUS, NON-STERILE, BOTTLE W/DISPENSER CAP,
240 ML (8 FL OZ); PH RANGE BETWEEN 5.0 AND 8.1.
.
OIL IN WATER OR WATER IN OIL EMULSION. SHALL CONTAIN A
MINIMUM OF THE FOLLOWING INGREDIENTS IN SUFFICIENT QUANTITIES<(>,<)>
WATER<(>,<)> A SUITABLE OIL<(>,<)> EMULSIFIER AND A PRESERVATIVE; OTHER
INGREDIENTS SUCH AS EMULSION STABILIZERS<(>,<)> THICKENING AGENTS<(>,<)>
EMOLLIENTS<(>,<)> SURFACTANTS<(>,<)> HUMECTANTS<(>,<)> COLORING AGENTS
AND FRAGRANCES MAY BE ADDED IN SUFFICIENT QUANTITIES.
.
STORE AT CONTROLLED ROOM TEMPERATURE. HAS VISCOSITY
OF 10,000 CPS TO 20,000 CPS AT 25 DEG C PORM 2 DEG C USING A BROOKFIELD
VISCOMETER MODEL LVT (OR QUIVALENT) W/SPINDLE NO. 13 AND SPEED 6 RPM
.
UNIT OF ISSUE: BOTTLE (BT) OF 8 FL OZ
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. ..
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00096-0722-08
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4182
SECTION B
PR: 7017514806 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017514806 0001 BT 250.000
NSN/MATERIAL:6508010197181
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N46245
MEDICAL TREATMENT FACILITY
USNS MERCY T AH 19
FPO AP 96672-4090
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N46245
MED TREATMENT FAC USNS MERCY T AH 1
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N4624561964242
RDD:
PROJ: TP 3
SUPP ADD: 784000 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A4A DIST: 9B ADV: 2A FC: E5
SPE2DP-26-T-4182
SECTION B
PR: 7017514806 PRLI: 0001 CONT’D
Need Ship Date:00/00/0000 Original Required Delivery Date:07/20/2026
SPE2DP-26-T-4182 NSN/Part Number: 6508-01-019-7181 Quantity: 250 BT Purchase Request: 7017514806QTY: 250 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency